Brokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) Price Target at $36.56

Surgery Partners, Inc. (NASDAQ:SGRY) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $36.56.

A number of analysts recently issued reports on SGRY shares. Macquarie reissued an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research note on Tuesday, November 19th. UBS Group assumed coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price objective on the stock. KeyCorp assumed coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. JPMorgan Chase & Co. lowered their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. Finally, Royal Bank of Canada cut their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th.

Surgery Partners Stock Down 2.7 %

Shares of NASDAQ:SGRY opened at $20.65 on Wednesday. The company has a 50 day moving average price of $23.00 and a two-hundred day moving average price of $27.30. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market capitalization of $2.62 billion, a PE ratio of -43.02, a PEG ratio of 17.40 and a beta of 2.58. Surgery Partners has a 52 week low of $19.50 and a 52 week high of $35.29.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. During the same quarter in the prior year, the company earned $0.15 EPS. Surgery Partners’s quarterly revenue was up 14.3% on a year-over-year basis. Analysts forecast that Surgery Partners will post 0.71 earnings per share for the current year.

Institutional Trading of Surgery Partners

A number of large investors have recently added to or reduced their stakes in SGRY. Harbor Capital Advisors Inc. boosted its stake in shares of Surgery Partners by 25.2% during the 4th quarter. Harbor Capital Advisors Inc. now owns 67,443 shares of the company’s stock worth $1,428,000 after acquiring an additional 13,588 shares during the period. JPMorgan Chase & Co. lifted its holdings in Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company’s stock valued at $6,107,000 after purchasing an additional 5,551 shares during the last quarter. Principal Financial Group Inc. bought a new position in Surgery Partners during the third quarter worth $1,469,000. Franklin Resources Inc. increased its holdings in shares of Surgery Partners by 19.5% in the third quarter. Franklin Resources Inc. now owns 21,324 shares of the company’s stock valued at $677,000 after purchasing an additional 3,487 shares during the last quarter. Finally, Sanctuary Advisors LLC bought a new position in shares of Surgery Partners in the third quarter valued at about $626,000.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.